Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study. - Ahmed, Fayyaz; Gaul, Charly; Kollewe, Katja; Singh, Ritu C.; Sommer, Katherine (BMC Neurology, 2025)